[
  {
    "ts": null,
    "headline": "3 Stocks Estimated To Be Trading At Discounts Of Up To 42.8%",
    "summary": "As the U.S. stock market navigates through a period of mixed performance with major indices setting new records despite challenges like a government shutdown, investors are keenly observing opportunities that may be undervalued amidst these fluctuations. In such an environment, identifying stocks that are trading at significant discounts can offer potential value, especially when considering broader economic factors and sector-specific developments.",
    "url": "https://finnhub.io/api/news?id=8e094453644651a0e1d2e44038e96d0b991e9aef4488e013235f866fb2893a05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759750690,
      "headline": "3 Stocks Estimated To Be Trading At Discounts Of Up To 42.8%",
      "id": 136990000,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "As the U.S. stock market navigates through a period of mixed performance with major indices setting new records despite challenges like a government shutdown, investors are keenly observing opportunities that may be undervalued amidst these fluctuations. In such an environment, identifying stocks that are trading at significant discounts can offer potential value, especially when considering broader economic factors and sector-specific developments.",
      "url": "https://finnhub.io/api/news?id=8e094453644651a0e1d2e44038e96d0b991e9aef4488e013235f866fb2893a05"
    }
  },
  {
    "ts": null,
    "headline": "DexCom May Be The Most Underrated Growth Story In Healthcare",
    "summary": "DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory risks. Learn why DXCM stock is a buy.",
    "url": "https://finnhub.io/api/news?id=5b7b474e0c33c72359174452ac872106bfac7e27e3a123d60725fd74ab842fc3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759732769,
      "headline": "DexCom May Be The Most Underrated Growth Story In Healthcare",
      "id": 136986785,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1367250756/image_1367250756.jpg?io=getty-c-w1536",
      "related": "DXCM",
      "source": "SeekingAlpha",
      "summary": "DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory risks. Learn why DXCM stock is a buy.",
      "url": "https://finnhub.io/api/news?id=5b7b474e0c33c72359174452ac872106bfac7e27e3a123d60725fd74ab842fc3"
    }
  }
]